49. Systemic lupus erythematosus Clinical trials / Disease details

Clinical trials : 993 /  Drugs : 702 - (DrugBank : 184) / Drug target genes : 116 - Drug target pathways : 200

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03527472
(ClinicalTrials.gov)		August 23, 20183/5/2018Memantine for the Treatment of Cognitive Impairment in Systemic Lupus ErythematosusA Randomized Placebo-controlled, Double Blind Phase 2 Clinical Trial of Memantine for the Treatment of Cognitive Impairment in Systemic Lupus ErythematosusLupus Erythematosus, SystemicDrug: Memantine;Drug: PlaceboVanderbilt University Medical CenterKleberg FoundationRecruiting18 Years70 YearsAll80Phase 2United States
2NCT00181298
(ClinicalTrials.gov)		March 200613/9/2005Memantine in Systemic Lupus ErythematosusMemantine in Systemic Lupus ErythematosusSystemic Lupus ErythematosusDrug: Memantine;Drug: PlaceboJohns Hopkins UniversityForest LaboratoriesCompleted18 YearsN/ABoth61N/AUnited States